ERGOMED Group is pleased to announce the expansion of its clinical operations in Europe with the opening of its representative office in Kiev, Ukraine. This development adds to ERGOMED Group extensive Eastern European operations that include our Moscow office and Russian operations. ERGOMED Group has been operating in Ukraine for many years and the establishment of the representative […]
ERGOMED Group is pleased to announce the expansion of its clinical operations in Europe with the opening of its representative office in Kiev, Ukraine. This development adds to ERGOMED Group extensive Eastern European operations that include our Moscow office and Russian operations.
ERGOMED Group has been operating in Ukraine for many years and the establishment of the representative office will enable further expansion of ERGOMED Group activities in the region.
ERGOMED Group is an established international CRO that has been providing excellent drug development services to biotech and pharma clients across the world for fifteen years. The expansion announced today is part of a strategy to ensure that ERGOMED Group has a corporate presence in countries that support clinical development activities and are a good source of large numbers of good quality patients.
ERGOMED Groupnow has 15 offices across Europe, North America and MENA region and is currently carrying out studies in 32 countries for a range of pharma and biotech clients.
About ERGOMED Group
ERGOMED Group is a specialised international clinical development company offering contract clinical research and co-development partnerships to biotechnology and pharmaceutical companies worldwide in the fields of neurology, oncology and immunology. ERGOMED Group approach to clinical research ensures effective patient recruitment, reducing the time and costs of clinical trials and complementing the drug discovery capabilities of its customers and partners. The Company has a dual business model offering standard clinical trial management contracts and also co-development partnerships to share the risks and rewards of clinical development. ERGOMED Group is headquartered in the UK, with additional operational offices in Cambridge, UK; Cologne and Frankfurt, Germany; Zagreb, Croatia; Krakow, Poland; Novi Sad, Serbia; Sarajevo, Bosnia and Herzegovina; Moscow, Russia; Madrid, Spain; Geneva, Switzerland; Asuncion, Paraguay; Kiev, Ukraine and San Antonio, USA as well as an office in Dubai that supports services in Middle East, North Africa and Turkey.
For further information visit www.ergomedgroup.com or alternatively please contact:
ERGOMED Group
Dr Miroslav Reljanovic, CEO
+385 (0) 1 4628 503
ergomed@ergomedgroup.com
ERGOMED Group
Neil Clark, CFO
+44 (0) 1223 370 111
neil.clark@ergomedgroup.com
